Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
MLSS 
Milestone Scientific (MLSS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: MLSS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $2.12
1 Year Target Price $2.12
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -48.8% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 49.95M USD | Price to earnings Ratio - | 1Y Target Price 2.12 |
Price to earnings Ratio - | 1Y Target Price 2.12 | ||
Volume (30-day avg) 2 | Beta 0.9 | 52 Weeks Range 0.57 - 1.39 | Updated Date 06/30/2025 |
52 Weeks Range 0.57 - 1.39 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.06 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -61.16% | Operating Margin (TTM) -89.49% |
Management Effectiveness
Return on Assets (TTM) -44.58% | Return on Equity (TTM) -88.36% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 55125321 | Price to Sales(TTM) 5.8 |
Enterprise Value 55125321 | Price to Sales(TTM) 5.8 | ||
Enterprise Value to Revenue 6.4 | Enterprise Value to EBITDA -6.86 | Shares Outstanding 78477296 | Shares Floating 61880152 |
Shares Outstanding 78477296 | Shares Floating 61880152 | ||
Percent Insiders 21.77 | Percent Institutions 5.33 |
Analyst Ratings
Rating 2 | Target Price 2.12 | Buy 1 | Strong Buy 1 |
Buy 1 | Strong Buy 1 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Milestone Scientific
Company Overview
History and Background
Milestone Scientific Inc. was founded in 1989. Initially focused on computer-controlled injection technology for various applications, it evolved to specialize in dental and medical markets. Significant milestones include FDA approvals for its CompuDent and STA systems and expansion into new applications like cosmetic injections.
Core Business Areas
- Dental: Develops, patents, designs, manufactures, and commercializes computer-controlled anesthetic delivery systems, primarily under the CompuDent and STA brands. These systems aim to provide more comfortable and precise dental injections.
- Medical: Focuses on expanding the application of its injection technology into other medical areas, including cosmetic injections and potentially biopsy/drug delivery.
Leadership and Structure
Leonard Osser serves as the Chief Executive Officer and President. The company operates with a functional organizational structure, encompassing research and development, manufacturing, sales and marketing, and finance and administration.
Top Products and Market Share
Key Offerings
- CompuDent/STA Dental Systems: Computer-controlled local anesthetic delivery systems for dentistry. Aims to provide a more precise and comfortable injection experience. Market share is estimated to be relatively small but growing, approximately <5% of the overall dental injection market. Competitors include traditional syringe manufacturers (e.g., Septodont, Dentsply Sirona) and other advanced injection systems (e.g., those offering buffered anesthetics).
- Milestone Scientific Medical Division: Developing and marketing injection solutions for cosmetic procedures and potentially other medical applications. Specific market share data is still developing, but the potential market is large. Competitors vary depending on the specific application, including established cosmetic injectable companies (e.g., Allergan, Galderma).
Market Dynamics
Industry Overview
The dental injection market is mature, but with increasing demand for patient comfort and precision. The medical injection market, particularly in aesthetics, is rapidly growing and competitive.
Positioning
Milestone Scientific positions itself as a technology innovator in the injection space, focusing on computer-controlled delivery for improved precision and patient experience. This provides a competitive advantage by differentiating from traditional manual syringes.
Total Addressable Market (TAM)
The total addressable market for dental and medical injections is estimated to be billions of dollars globally. Milestone Scientific is positioned to capture a larger share of this TAM by expanding its product offerings and entering new market segments.
Upturn SWOT Analysis
Strengths
- Patented computer-controlled injection technology
- Focus on patient comfort and precision
- Potential for expansion into new medical applications
- Established brand in dental market
Weaknesses
- Relatively small market share compared to larger competitors
- Limited financial resources for marketing and sales
- Dependence on regulatory approvals for new products
- Concentration of sales in the dental market
Opportunities
- Expanding into the growing cosmetic injection market
- Developing new applications for its technology in other medical fields
- Partnering with larger medical device companies
- Increasing awareness of its products through targeted marketing campaigns
Threats
- Competition from established companies with greater resources
- Technological advancements from competitors
- Changes in regulatory requirements
- Economic downturn affecting dental and cosmetic procedures
Competitors and Market Share
Key Competitors
- Dentsply Sirona (XRAY)
- Envista Holdings (NVST)
- Septodont (Private)
Competitive Landscape
Milestone Scientific faces competition from large, established dental equipment manufacturers with significantly greater resources. However, its focus on computer-controlled injection technology provides a differentiating factor.
Growth Trajectory and Initiatives
Historical Growth: Growth has been uneven, with periods of rapid revenue increase followed by declines. Requires detailed analysis of revenue streams and market conditions.
Future Projections: Analyst projections are mixed, depending on the success of new product launches and expansion into new markets. Subject to change.
Recent Initiatives: Recent initiatives include expanding the use of its injection technology into new applications in cosmetic injections.
Summary
Milestone Scientific is a small, innovative company with promising injection technology, but it faces significant challenges. The company's innovative technology and entry into medical applications like cosmetics could drive growth, but are also highly dependent on market conditions and regulatory approvals. It faces considerable competition from large players with strong financial backing and established distribution networks. Further, financial resources and sustained profitability are critical to the company's long-term sustainability and success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (SEC)
- Investor Presentations
- Industry Reports
- Analyst Estimates
Disclaimers:
The data provided is for informational purposes only and should not be considered financial advice. Market share data are estimates and may vary. Financial data is based on publicly available information and may not be complete or accurate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Milestone Scientific
Exchange NYSE MKT | Headquaters Roseland, NJ, United States | ||
IPO Launch date 1995-11-03 | Chairman of the Board & Interim CEO Mr. Neal Ira Goldman CFA | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 17 | |
Full time employees 17 | |||
Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.